Shire To Pay Record-Setting Device FCA Settlement
Executive Summary
The $350m settlement resolves False Claims Act allegations Shire and its subsidiaries used tactics including lavish meals, free medical equipment, unearned speaker payments and cash to encourage doctors to prescribe the company’s Dermagraft human skin substitute.
You may also be interested in...
Medtech And US DoJ: EpiPen, Dermagraft Lead 2017 Payouts To Feds
US DoJ collected more than $1bn in penalties from device manufacturers this year, chiefly on false claims and manufacturing violations. Here is a roundup and sortable table of the payouts.
Unlocking Legalities: False-Claim Standards Continue To Evolve
The finer points of when exactly the US government can collect from a device company for selling it a bill of goods are under reconsideration, even as the fast pace of False Claims Act suits continues, attorneys with law firm Gibson Dunn concluded during a series of recent webinars.
Zimmer Faces HHS Inspector General Subpoena
The orthopedics manufacturer announced in a recent filing that the US Health and Human Services watchdog has asked for a range of records related to health-care consulting arrangements.